Research graph
References from Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients. Local targets link to admitted publications; unresolved targets remain external evidence.
Pneumocystis jirovecii: A peculiar fungus posing particular problems for therapy and prophylaxis
2012 · External reference
Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing
2022 · External reference
Management of pneumocystis jirovecii pneumonia in HIV infected patients: Current options, challenges and future directions
2010 · External reference
Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
10.1186/s12890-022-02300-8 · 2023 · External reference
Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients
10.1016/j.jiac.2014.03.003 · 2014 · External reference
Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study
2021 · External reference
Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: A systematic literature review of published case reports and disproportionality analysis based on the FAERS database
2023 · External reference
Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients
2022 · External reference
Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness
2021 · External reference
Risk of and prophylaxis against PCP pneumonia among HIV-uninfected individuals
2018 · External reference
Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis
10.1371/journal.pone.0250611 · 2021 · External reference
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
2020 · External reference
Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals
2014 · External reference
A Rare Case of Ulcerative Colitis with Severe Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review
2022 · External reference
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
10.3390/jof9080838 · 2023 · External reference
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/μL
10.1002/jia2.25726 · 2021 · External reference
Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
10.3389/fcimb.2020.00224 · 2020 · External reference
Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway
10.1186/s12879-021-06144-1 · 2021 · External reference
Molecular detection of Pneumocystis jirovecii by real-time PCR: Sensitivity depends on the target selection
10.1016/j.ijid.2014.03.1188 · 2014 · External reference
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
10.1111/j.1469-0691.2010.03400.x · 2011 · External reference
Development and Evaluation of a Fully Automated Molecular Assay Targeting the Mitochondrial Small Subunit rRNA Gene for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid Specimens
2020 · External reference
The Persistent Challenge of Pneumocystis Growth Outside the Mammalian Lung: Past and Future Approaches
2021 · External reference
Immune response in pneumocystis infections according to the host immune system status
2021 · External reference
Murine models of Pneumocystis infection recapitulate human primary immune disorders
10.1172/jci.insight.91894 · 2018 · External reference
New advances in understanding the host immune response to Pneumocystis
2017 · External reference
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
10.1186/2046-4053-4-1 · 2015 · External reference
PROSPERO: An International Register of Systematic Review Protocols
2019 · External reference
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
2021 · External reference
